In a discussion regarding TREK-1 inhibitors, a user highlighted that PE 22-28 serves as a shortened analog of spadin with a significantly improved duration of action. The peptide reportedly maintains its effects for up to 23 hours, a substantial increase over the 7-hour duration associated with the original spadin molecule.